BS ISO 5910:2024
$215.11
Cardiovascular implants and extracorporeal systems. Cardiac valve repair devices
Published By | Publication Date | Number of Pages |
BSI | 2024 | 108 |
PDF Catalog
PDF Pages | PDF Title |
---|---|
2 | undefined |
7 | Foreword |
9 | 1 Scope 2 Normative references |
10 | 3 Terms and definitions |
17 | 4 Abbreviated terms |
18 | 5 Fundamental requirements 5.1 General 5.2 Risk management 6 Device design 6.1 Intended use and indication for use 6.2 Design inputs 6.2.1 General 6.2.2 Operational specifications |
20 | 6.2.3 Functional, performance and safety requirements |
21 | 6.2.4 Usability 6.2.5 Packaging, labelling and sterilization 6.3 Design outputs 6.4 Design transfer (manufacturing verification and validation) |
22 | 7 Design verification testing and analysis, and design validation 7.1 General requirements 7.2 In vitro assessment 7.2.1 General 7.2.2 Test articles, sample selection, test conditions and reporting requirements |
24 | 7.2.3 Device material property assessment |
25 | 7.2.4 Device durability assessment 7.2.5 Device corrosion assessment 7.2.6 Design specific testing 7.2.7 Visibility |
26 | 7.2.8 Simulated use assessment 7.2.9 Human factors and usability assessment 7.2.10 Device MRI safety 7.3 Preclinical in vivo evaluation 7.3.1 General 7.3.2 Overall requirements |
28 | 7.3.3 Methods |
29 | 7.3.4 Test report |
30 | 7.4 Clinical investigations 7.4.1 General 7.4.2 Study considerations |
32 | 7.4.3 Study end points |
33 | 7.4.4 Ethical considerations 7.4.5 Distribution of subjects and investigators |
34 | 7.4.6 Statistical considerations including sample size and duration |
35 | 7.4.7 Patient selection criteria |
36 | 7.4.8 Clinical data requirements |
39 | 7.4.9 Clinical investigation analysis and reporting 7.4.10 Post-market clinical follow-up |
40 | 8 Manufacturing verification and validation |
41 | Annex A (informative) Rationale for the provisions of this document |
44 | Annex B (informative) Types and examples of heart valve repair devices and delivery systems |
51 | Annex C (normative) Packaging |
52 | Annex D (normative) Product labels, instructions for use and training |
55 | Annex E (normative) Sterilization |
56 | Annex F (informative) Heart valve repair system characteristics |
58 | Annex G (informative) Example of a transcatheter heart valve repair system hazard analysis |
59 | Annex H (informative) In vitro test guidelines for paediatric devices |
62 | Annex I (informative) Identification of boundary conditions |
66 | Annex J (informative) Test platforms for in vitro testing |
68 | Annex K (informative) Considerations for device material properties undergoing alterations post implantation |
69 | Annex L (informative) Corrosion assessment |
72 | Annex M (informative) Durability assessment |
79 | Annex N (informative) Additional device design evaluation considerations |
82 | Annex O (normative) Delivery system design evaluation |
84 | Annex P (informative) Preclinical ex vivo and in vivo evaluations |
88 | Annex Q (normative) Adverse event classification during clinical investigation |
94 | Annex R (informative) Multimodality imaging of TAVr, TMVr and TTVr (pre-, peri- and post-implantation) |
99 | Annex S (informative) Clinical investigation end points for valve repair devices: Suggestions for end points and their timing |
103 | Bibliography |